Article
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Scientific reports - 28 Apr 2020
Yoneyama Seigo, Sakurada Yoichi, Kikushima Wataru, Sugiyama Atsushi, Matsubara Mio, Fukuda Yoshiko, Tanabe Naohiko, Parikh Ravi, Mabuchi Fumihiko, Kashiwagi Kenji, Iijima Hiroyuki
Abstract excerpt
In the present study, we investigated the association between susceptible genetic variants to age-related macular degeneration (AMD) and response to as-needed intravitreal aflibercept injection (IAI) therapy for exudative AMD including both typical neovascular AMD and polypoidal choroidal vasculopathy (PCV) over 12-months. A total of 234 patients with exudative AMD were initially treated with 3 monthly IAI and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.